Evaluating the Safety of Etanercept 50 mg Twice Weekly in Subjects With Psoriasis
Clinical trial NCT00111449 · COMPLETED
Trial details
- NCT number
- NCT00111449
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2003-06-01
- Enrollment
- 600
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.